Paxlovid does not prevent Covid-19 infection if shared with F0
The firm covid-19-cho-nguoi-tu-65-year-old-post1439126.html” title=”Pfizer-BioNTech proposes certification of 4 doses of Covid-19 vaccines for people aged 65 and over”>Pfizer (USA) yesterday announced test results Experiments on more than 3,000 adults show that the Covid-19 drug Paxlovid (image) is not effective in preventing infection if you share a house with a Covid-19 patient, according to Reuters.
All trial participants were in the same house as the patient Covid-19 symptoms and were divided into 3 groups, taking the drug for 5 days, 10 days, or taking a placebo.
The results showed that people who took the drug for 5 days had a 32% lower infection rate than the placebo group. The number of the 10-day pill group was 37%, which did not change significantly.
 |
Pfizer said the results were “disappointing” but did not affect the safety data of Paxlovid observed in previous studies.
According to the pharmaceutical company, Paxlovid is 90% effective in preventing hospitalization or death in Covid-19 patient belongs to the high-risk group if the drug is used within 5 days of the onset of symptoms.
Pfizer said Paxlovid has been conditionally or urgently approved in more than 60 countries to treat high-risk Covid-19 patients.
at Blogtuan.info – Source: thanhnien.vn – Read the original article here
